Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters
4.5 (564) · € 14.50 · En Stock
Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolism
Proteomic Landscape of a Drug-Tolerant Persister Subpopulation of Mycobacterium tuberculosis
Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide
Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolism
PK profiles of individual drugs in at-risk patients relative to MIC.
Pharmacological and genetic activation of cAMP synthesis disrupts cholesterol utilization in Mycobacterium tuberculosis
Drug penetration in vivo. Relationship between the fraction unbound ( f
The significance of persisters in tuberculosis drug discovery: Exploring the potential of targeting the glyoxylate shunt pathway - ScienceDirect
Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis
Frontiers Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
Identification of host regulators of Mycobacterium tuberculosis phenotypes uncovers a role for the MMGT1-GPR156 lipid droplet axis in persistence - ScienceDirect
Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model
Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum
Immune evasion and provocation by Mycobacterium tuberculosis
Immune evasion and provocation by Mycobacterium tuberculosis
